Biological Implants Market Size, Share & Trends Analysis Report By Product (Autografts, Allografts), By Mode of Administration (Surgical, Injectable), By Application (Cardiovascular Implants), By Region, And Segment Forecasts, 2023

The global biological implants market size is expected to reach USD 13.61 billion by 2030, according to a new report by Grand View Research, Inc.., registering a CAGR of 7.2% from 2023 to 2030. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

Biological Implants Market Report Highlights:

Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2022 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune implants reaction, thereby influencing adoption rate.
Biological serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2022 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
North America dominated the market with a revenue share of 50.3% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Product Code: GVR-1-68038-270-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Mode of Administration
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Mode of administration outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Biological Implants Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Biological Implants Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Biological Implants: Product Estimates & Trend Analysis

4.1. Biological Implants Market: Key Takeaways
4.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Autografts
- 4.3.1. Autografts market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Allografts
- 4.4.1. Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Xenografts
- 4.5.1. Xenografts market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biological Implants: Application Estimates & Trend Analysis

5.1. Biological Implants Market: Key Takeaways
5.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Cardiovascular Implants
- 5.3.1. Cardiovascular implants market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Orthopedic Implants
- 5.4.1. Orthopedic implants market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Other Soft Tissue Implants
- 5.5.1. Other soft tissue implants market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biological Implants: Mode of Administration Estimates & Trend Analysis

6.1. Biological Implants Market: Key Takeaways
6.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Surgical
- 6.3.1. Surgical market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Injectable
- 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biological Implants Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Biological Implants Market by Region: Key Takeaways
7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. South Africa
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
- 8.2.1. Integra LifeSciences
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. NuVasive, Inc.
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Edwards Lifesciences Corporation
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Stryker
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. LifeCell International Pvt. Ltd.
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. Medtronic
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. Osteotec Limited
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. RTI Surgical
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. BioPolymer GmbH & Co KG
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives
- 8.2.10. Johnson & Johnson Private Limited
  - 8.2.10.1. Company overview
  - 8.2.10.2. Financial performance
  - 8.2.10.3. Product benchmarking
  - 8.2.10.4. Strategic initiatives
- 8.2.11. Baxter
  - 8.2.11.1. Company overview
  - 8.2.11.2. Financial performance
  - 8.2.11.3. Product benchmarking
  - 8.2.11.4. Strategic initiatives
- 8.2.12. Vericel
  - 8.2.12.1. Company overview
  - 8.2.12.2. Financial performance
  - 8.2.12.3. Product benchmarking
  - 8.2.12.4. Strategic initiatives
- 8.2.13. ATEC Spine, Inc
  - 8.2.13.1. Company overview
  - 8.2.13.2. Financial performance
  - 8.2.13.3. Product benchmarking
  - 8.2.13.4. Strategic initiatives
- 8.2.14. Artivion, Inc
  - 8.2.14.1. Company overview
  - 8.2.14.2. Financial performance
  - 8.2.14.3. Product benchmarking
  - 8.2.14.4. Strategic initiatives
- 8.2.15. Maxigen Biotech Inc.
  - 8.2.15.1. Company overview
  - 8.2.15.2. Financial performance
  - 8.2.15.3. Product benchmarking
  - 8.2.15.4. Strategic initiatives
- 8.2.16. Implandata Ophthalmic Products GmbH
  - 8.2.16.1. Company overview
  - 8.2.16.2. Financial performance
  - 8.2.16.3. Product benchmarking
  - 8.2.16.4. Strategic initiatives
- 8.2.17. CONMED Corporation
  - 8.2.17.1. Company overview
  - 8.2.17.2. Financial performance
  - 8.2.17.3. Product benchmarking
  - 8.2.17.4. Strategic initiatives
- 8.2.18. AbbVie Inc.
  - 8.2.18.1. Company overview
  - 8.2.18.2. Financial performance
  - 8.2.18.3. Product benchmarking
  - 8.2.18.4. Strategic initiatives
- 8.2.19. BioTissue
  - 8.2.19.1. Company overview
  - 8.2.19.2. Financial performance
  - 8.2.19.3. Product benchmarking
  - 8.2.19.4. Strategic initiatives
- 8.2.20. Auto Tissue Berlin GmbH
  - 8.2.20.1. Company overview
  - 8.2.20.2. Financial performance
  - 8.2.20.3. Product benchmarking
  - 8.2.20.4. Strategic initiatives
- 8.2.21. MIMEDX Group, Inc.
  - 8.2.21.1. Company overview
  - 8.2.21.2. Financial performance
  - 8.2.21.3. Product benchmarking
  - 8.2.21.4. Strategic initiatives
- 8.2.22. Organogenesis Inc.
  - 8.2.22.1. Company overview
  - 8.2.22.2. Financial performance
  - 8.2.22.3. Product benchmarking
  - 8.2.22.4. Strategic initiatives
- 8.2.23. Smith+Nephew
  - 8.2.23.1. Company overview
  - 8.2.23.2. Financial performance
  - 8.2.23.3. Product benchmarking
  - 8.2.23.4. Strategic initiatives

Product Code: GVR-1-68038-270-9

List of Tables

Table 1 List of Abbreviations
Table 2 North America biological implants market, by product, 2018 - 2030 (USD Million)
Table 3 North America biological implants market, by application, 2018 - 2030 (USD Million)
Table 4 North America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 5 North America biological implants market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. biological implants market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. biological implants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 9 Canada biological implants market, by product, 2018 - 2030 (USD Million)
Table 10 Canada biological implants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 12 Europe biological implants market, by product, 2018 - 2030 (USD Million)
Table 13 Europe biological implants market, by application, 2018 - 2030 (USD Million)
Table 14 Europe biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 15 Europe biological implants market, by region, 2018 - 2030 (USD Million)
Table 16 Germany biological implants market, by product, 2018 - 2030 (USD Million)
Table 17 Germany biological implants market, by application, 2018 - 2030 (USD Million)
Table 18 Germany biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 19 UK biological implants market, by product, 2018 - 2030 (USD Million)
Table 20 UK biological implants market, by application, 2018 - 2030 (USD Million)
Table 21 UK biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 22 France biological implants market, by product, 2018 - 2030 (USD Million)
Table 23 France biological implants market, by application, 2018 - 2030 (USD Million)
Table 24 France biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 25 Italy biological implants market, by product, 2018 - 2030 (USD Million)
Table 26 Italy biological implants market, by application, 2018 - 2030 (USD Million)
Table 27 Italy biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 28 Spain biological implants market, by product, 2018 - 2030 (USD Million)
Table 29 Spain biological implants market, by application, 2018 - 2030 (USD Million)
Table 30 Spain biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 31 Sweden biological implants market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden biological implants market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 34 Norway biological implants market, by product, 2018 - 2030 (USD Million)
Table 35 Norway biological implants market, by application, 2018 - 2030 (USD Million)
Table 36 Norway biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 37 Denmark biological implants market, by product, 2018 - 2030 (USD Million)
Table 38 Denmark biological implants market, by application, 2018 - 2030 (USD Million)
Table 39 Denmark biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 40 Asia Pacific biological implants market, by product, 2018 - 2030 (USD Million)
Table 41 Asia Pacific biological implants market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific biological implants market, by region, 2018 - 2030 (USD Million)
Table 44 Japan biological implants market, by product, 2018 - 2030 (USD Million)
Table 45 Japan biological implants market, by application, 2018 - 2030 (USD Million)
Table 46 Japan biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 47 China biological implants market, by product, 2018 - 2030 (USD Million)
Table 48 China biological implants market, by application, 2018 - 2030 (USD Million)
Table 49 China biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 50 India biological implants market, by product, 2018 - 2030 (USD Million)
Table 51 India biological implants market, by application, 2018 - 2030 (USD Million)
Table 52 India biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 53 Australia biological implants market, by product, 2018 - 2030 (USD Million)
Table 54 Australia biological implants market, by application, 2018 - 2030 (USD Million)
Table 55 Australia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 56 Thailand biological implants market, by product, 2018 - 2030 (USD Million)
Table 57 Thailand biological implants market, by application, 2018 - 2030 (USD Million)
Table 58 Thailand biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 59 South Korea biological implants market, by product, 2018 - 2030 (USD Million)
Table 60 South Korea biological implants market, by application, 2018 - 2030 (USD Million)
Table 61 South Korea biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 62 Latin America biological implants market, by product, 2018 - 2030 (USD Million)
Table 63 Latin America biological implants market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 65 Latin America biological implants market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil biological implants market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil biological implants market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 69 Mexico biological implants market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico biological implants market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 72 Argentina biological implants market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina biological implants market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa biological implants market, by product, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa biological implants market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa biological implants market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa biological implants market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa biological implants market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia biological implants market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia biological implants market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 85 UAE biological implants market, by product, 2018 - 2030 (USD Million)
Table 86 UAE biological implants market, by application, 2018 - 2030 (USD Million)
Table 87 UAE biological implants market, by mode of administration, 2018 - 2030 (USD Million)
Table 88 Kuwait biological implants market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait biological implants market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait biological implants market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Biological implants: Market outlook
Fig. 8 Biological implants: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Biological implants market driver impact
Fig. 14 Biological implants market restraint impact
Fig. 15 Biological implants market strategic initiatives analysis
Fig. 16 Biological implants market: Product movement analysis
Fig. 17 Biological implants market: Product outlook and key takeaways
Fig. 18 Autografts market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Allografts market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Xenografts market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Biological implants market: Application movement analysis
Fig. 22 Biological implants market: Application outlook and key takeaways
Fig. 23 Cardiovascular implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Orthopedic implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Other soft tissue implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Biological implants market: Mode of administration movement analysis
Fig. 27 Biological implants market: Mode of administration outlook and key takeaways
Fig. 28 Surgical market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Global biological implants market: Regional movement analysis
Fig. 31 Global biological implants market: Regional outlook and key takeaways
Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Biological Implants Market Size, Share & Trends Analysis Report By Product (Autografts, Allografts), By Mode of Administration (Surgical, Injectable), By Application (Cardiovascular Implants), By Region, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Biological Implants Market Growth & Trends:

Biological Implants Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Biological Implants Market Variables, Trends & Scope

Chapter 4. Biological Implants: Product Estimates & Trend Analysis

Chapter 5. Biological Implants: Application Estimates & Trend Analysis

Chapter 6. Biological Implants: Mode of Administration Estimates & Trend Analysis

Chapter 7. Biological Implants Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures